139 related articles for article (PubMed ID: 22546668)
1. Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism.
Bhondwe RS; Kang DW; Kim MS; Kim HS; Park SG; Son K; Choi S; Kuhs KA; Pavlyukovets VA; Pearce LV; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2012 Jun; 22(11):3656-60. PubMed ID: 22546668
[TBL] [Abstract][Full Text] [Related]
2. Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
Lee J; Kang SU; Kil MJ; Shin M; Lim JO; Choi HK; Jin MK; Kim SY; Kim SE; Lee YS; Min KH; Kim YH; Ha HJ; Tran R; Welter JD; Wang Y; Szabo T; Pearce LV; Lundberg DJ; Toth A; Pavlyukovets VA; Morgan MA; Blumberg PM
Bioorg Med Chem Lett; 2005 Sep; 15(18):4136-42. PubMed ID: 16005215
[TBL] [Abstract][Full Text] [Related]
3. Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.
Chung JU; Kim SY; Lim JO; Choi HK; Kang SU; Yoon HS; Ryu H; Kang DW; Lee J; Kang B; Choi S; Toth A; Pearce LV; Pavlyukovets VA; Lundberg DJ; Blumberg PM
Bioorg Med Chem; 2007 Sep; 15(18):6043-53. PubMed ID: 17629487
[TBL] [Abstract][Full Text] [Related]
4. Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
Lee J; Jin MK; Kang SU; Kim SY; Lee J; Shin M; Hwang J; Cho S; Choi YS; Choi HK; Kim SE; Suh YG; Lee YS; Kim YH; Ha HJ; Toth A; Pearce LV; Tran R; Szabo T; Welter JD; Lundberg DJ; Wang Y; Lazar J; Pavlyukovets VA; Morgan MA; Blumberg PM
Bioorg Med Chem Lett; 2005 Sep; 15(18):4143-50. PubMed ID: 15993063
[TBL] [Abstract][Full Text] [Related]
5. Analysis of structure-activity relationships with the N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism.
Lee J; Kim SY; Lee J; Kang M; Kil MJ; Choi HK; Jin MK; Wang Y; Toth A; Pearce LV; Lundberg DJ; Tran R; Blumberg PM
Bioorg Med Chem; 2004 Jul; 12(13):3411-20. PubMed ID: 15186827
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
Ryu H; Jin MK; Kim SY; Choi HK; Kang SU; Kang DW; Lee J; Pearce LV; Pavlyukovets VA; Morgan MA; Tran R; Toth A; Lundberg DJ; Blumberg PM
J Med Chem; 2008 Jan; 51(1):57-67. PubMed ID: 18072720
[TBL] [Abstract][Full Text] [Related]
7. α-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonists.
Kim HS; Jin MK; Kang SU; Lim JO; Tran PT; Hoang VH; Ann J; Ha TH; Pearce LV; Pavlyukovets VA; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2014 Jun; 24(12):2685-8. PubMed ID: 24794110
[TBL] [Abstract][Full Text] [Related]
8. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
Lee J; Lee J; Kang M; Shin M; Kim JM; Kang SU; Lim JO; Choi HK; Suh YG; Park HG; Oh U; Kim HD; Park YH; Ha HJ; Kim YH; Toth A; Wang Y; Tran R; Pearce LV; Lundberg DJ; Blumberg PM
J Med Chem; 2003 Jul; 46(14):3116-26. PubMed ID: 12825950
[TBL] [Abstract][Full Text] [Related]
9. Halogenation of 4-hydroxy/amino-3-methoxyphenyl acetamide TRPV1 agonists showed enhanced antagonism to capsaicin.
Kang DW; Kim YS; Lim KS; Kim MS; Pearce LV; Pavlyukovets VA; Tao AK; Lang-Kuhs KA; Blumberg PM; Lee J
Bioorg Med Chem; 2010 Nov; 18(22):8092-105. PubMed ID: 20937561
[TBL] [Abstract][Full Text] [Related]
10. Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin.
Kang DW; Ryu H; Lee J; Lang KA; Pavlyukovets VA; Pearce LV; Ikeda T; Lazar J; Blumberg PM
Bioorg Med Chem Lett; 2007 Jan; 17(1):214-9. PubMed ID: 17035013
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding.
Lee J; Kim SY; Park S; Lim JO; Kim JM; Kang M; Lee J; Kang SU; Choi HK; Jin MK; Welter JD; Szabo T; Tran R; Pearce LV; Toth A; Blumberg PM
Bioorg Med Chem; 2004 Mar; 12(5):1055-69. PubMed ID: 14980619
[TBL] [Abstract][Full Text] [Related]
12. N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.
Kim YS; Kil MJ; Kang SU; Ryu H; Kim MS; Cho Y; Bhondwe RS; Thorat SA; Sun W; Liu K; Lee JH; Choi S; Pearce LV; Pavlyukovets VA; Morgan MA; Tran R; Lazar J; Blumberg PM; Lee J
Bioorg Med Chem; 2012 Jan; 20(1):215-24. PubMed ID: 22169633
[TBL] [Abstract][Full Text] [Related]
13. Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N(')-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity.
Lee J; Kang SU; Choi HK; Lee J; Lim JO; Kil MJ; Jin MK; Kim KP; Sung JH; Chung SJ; Ha HJ; Kim YH; Pearce LV; Tran R; Lundberg DJ; Wang Y; Toth A; Blumberg PM
Bioorg Med Chem Lett; 2004 May; 14(9):2291-7. PubMed ID: 15081027
[TBL] [Abstract][Full Text] [Related]
14. Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.
Feng Z; Pearce LV; Xu X; Yang X; Yang P; Blumberg PM; Xie XQ
J Chem Inf Model; 2015 Mar; 55(3):572-88. PubMed ID: 25642729
[TBL] [Abstract][Full Text] [Related]
15. 3-D-QSAR analysis of N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline and N-(3-acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thioureas analogues as potent vanilloid receptor ligands.
Kim KH
Bioorg Med Chem; 2002 May; 10(5):1367-72. PubMed ID: 11886800
[TBL] [Abstract][Full Text] [Related]
16. N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the "C-Region".
Lee J; Kang SU; Lim JO; Choi HK; Jin MK; Toth A; Pearce LV; Tran R; Wang Y; Szabo T; Blumberg PM
Bioorg Med Chem; 2004 Jan; 12(2):371-85. PubMed ID: 14723956
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies.
Lee JH; Lee Y; Ryu H; Kang DW; Lee J; Lazar J; Pearce LV; Pavlyukovets VA; Blumberg PM; Choi S
J Comput Aided Mol Des; 2011 Apr; 25(4):317-27. PubMed ID: 21448716
[TBL] [Abstract][Full Text] [Related]
18. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities.
Kim NJ; Li FN; Lee JH; Park SG; Kim K; Lim C; Han YT; Yun H; Jung JW; Park HG; Kim HD; Woo BY; Shin SS; Kim SY; Choi JK; Jeong YS; Park Y; Park YH; Kim DD; Choi S; Suh YG
Chem Asian J; 2013 Feb; 8(2):400-9. PubMed ID: 23208797
[TBL] [Abstract][Full Text] [Related]
19. Receptor activity and conformational analysis of 5'-halogenated resiniferatoxin analogs as TRPV1 ligands.
Lim KS; Kang DW; Kim YS; Kim MS; Park SG; Choi S; Pearce LV; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2011 Jan; 21(1):299-302. PubMed ID: 21111618
[TBL] [Abstract][Full Text] [Related]
20. α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists.
Tran PT; Kim HS; Ann J; Kim SE; Kim C; Hong M; Hoang VH; Ngo VT; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2015 Jun; 25(11):2326-30. PubMed ID: 25937016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
